Thursday, 3 April 2025
  
Login

Australia's most trusted
source of pharma news

Thursday, 03 April 2025
News

Drugs quietly listed on the PBS

Posted 2 April 2025 AM 

While the Albanese Government has been drip-feeding PBS listings as far out as May ahead of the Federal Election, there were still some surprise additions to the scheme this month.

Overall, there were nine additions to the scheme for April, including BeiGene’s Tevimbra for advanced or metastatic gastro-oesophageal cancer, which joins a growing list of PD-1 inhibitors on the PBS and marks the company’s second product subsided in Australia following Brukinsa.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (20)

Clinical & Medical, R&D (7)

Regulatory, Pharmacovigilance & QA (5)

Other (18)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.